Works matching DE "THERAPEUTIC use of antineoplastic agents"
Results: 5000
Capivasertib treatment associated with hypermetabolism of the spleen.
- Published in:
- EJNMMI Reports, 2025, v. 9, n. 1, p. 1, doi. 10.1186/s41824-024-00231-7
- By:
- Publication type:
- Article
Diffuse Large B-Cell Lymphoma of the Frontal Sinus: A Case Report.
- Published in:
- ENT: Ear, Nose & Throat Journal, 2025, v. 104, n. 4, p. NP178, doi. 10.1177/01455613221101089
- By:
- Publication type:
- Article
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer.
- Published in:
- CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 2, p. 87, doi. 10.3322/caac.70003
- By:
- Publication type:
- Article
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.
- Published in:
- CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 2, p. 141, doi. 10.3322/caac.21870
- By:
- Publication type:
- Article
Real‐Practice Analysis of Potential Antibiotic Interactions in Patients Treated With Immune Checkpoint Inhibitors: An Observational Study From an Italian Referral Cancer Center.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2025, v. 2025, p. 1, doi. 10.1155/jcpt/5572209
- By:
- Publication type:
- Article
Rare Histological Types of Breast Cancer: A Single‐Center Experience.
- Published in:
- Breast Journal, 2025, v. 2025, p. 1, doi. 10.1155/tbj/1179914
- By:
- Publication type:
- Article
Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model.
- Published in:
- European Journal of Oral Sciences, 2025, v. 133, n. 1, p. 1, doi. 10.1111/eos.13034
- By:
- Publication type:
- Article
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae369
- By:
- Publication type:
- Article
Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae320
- By:
- Publication type:
- Article
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae260
- By:
- Publication type:
- Article
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae262
- By:
- Publication type:
- Article
Conference Highlights. 25TH ANNUAL MEETING OF THE SOCIETY OF UROLOGIC ONCOLOGY.
- Published in:
- 2025
- By:
- Publication type:
- Abstract
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight: Targeting HER2 in Gastroesophageal Cancer: A. Cammarota et al.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 361, doi. 10.1007/s40265-024-02132-2
- By:
- Publication type:
- Article
Patient Preferences for HR+/HER2− Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice Experiment.
- Published in:
- Breast Care, 2025, v. 20, n. 1, p. 16, doi. 10.1159/000543320
- By:
- Publication type:
- Article
Expert Discussion: ESMO 2024.
- Published in:
- 2025
- By:
- Publication type:
- Conference Paper/Materials
Systematic review and meta-analysis of artificial intelligence in classifying HER2 status in breast cancer immunohistochemistry.
- Published in:
- NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01483-8
- By:
- Publication type:
- Article
Utility of Assessing Early Tumor Shrinkage as an Efficacy Predictor in Patients with Non-Surgically Indicated or Recurrent Esophageal Cancer Treated with Nivolumab plus Ipilimumab.
- Published in:
- Oncology, 2025, v. 103, n. 3, p. 167, doi. 10.1159/000540851
- By:
- Publication type:
- Article
Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis.
- Published in:
- Oncology, 2025, v. 103, n. 3, p. 179, doi. 10.1159/000540515
- By:
- Publication type:
- Article
Risk Prediction Model for Surgical Complications and Predictors of Delay/Omission of Adjuvant Chemotherapy Post Primary Cytoreduction in Epithelial Ovarian Cancer.
- Published in:
- Indian Journal of Surgery, 2025, v. 87, n. 1, p. 60, doi. 10.1007/s12262-024-04089-8
- By:
- Publication type:
- Article
MONALEESA-2 Trial—A Beacon of Hope.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Frankincense Oil: A Natural Remedy with Promising but Unproven Cancer Benefits.
- Published in:
- Indian Practitioner, 2025, v. 78, n. 2, p. 31
- Publication type:
- Article
3 Things You Should Know About Treating Epithelioid Sarcoma.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 88
- Publication type:
- Article
Sotorasib Combo Bests Chemo Leading to Approval in KRAS G12C+ CRC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 85
- By:
- Publication type:
- Article
Overall survival with pembrolizumab in early-stage triple-negative breast cancer.
- Published in:
- Breast Cancer Research Review, 2025, n. 46, p. 5
- By:
- Publication type:
- Article
Essential barriers and considerations for the implementation of electronic patient-reported outcome (ePRO) measures in oncological practice: contextualizing the results of a feasibility study with existing literature.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2023, v. 31, n. 12, p. 2071, doi. 10.1007/s10389-022-01767-3
- By:
- Publication type:
- Article
Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 217, doi. 10.1007/s40487-025-00326-6
- By:
- Publication type:
- Article
The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 201, doi. 10.1007/s40487-025-00325-7
- By:
- Publication type:
- Article
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 165, doi. 10.1007/s40487-024-00322-2
- By:
- Publication type:
- Article
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) DLBCL with CAR T Cell Therapy: A Vodcast and Case Example.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 11, doi. 10.1007/s40487-024-00319-x
- By:
- Publication type:
- Article
Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 253, doi. 10.1007/s40487-024-00318-y
- By:
- Publication type:
- Article
Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 85, doi. 10.1007/s40487-024-00311-5
- By:
- Publication type:
- Article
Antitumor activity of gamma-irradiated Rosa canina L. against lung carcinoma in rat model: a proposed mechanism.
- Published in:
- BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-04813-1
- By:
- Publication type:
- Article
Enfortumab Vedotin Plus Pembrolizumab Compared to Pembrolizumab and Standard Chemotherapy: Birds of a Feather Flock Together in Urothelial Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Antifungal Prophylaxis in the Treatment Combination of Hypomethylating Agents and Venetoclax for AML: A Survey Study of the Turkish Society of Hematology Subcommittee on Infections and Supportive Therapies in Hematology.
- Published in:
- Turkish Journal of Hematology, 2025, v. 42, n. 1, p. 69, doi. 10.4274/tjh.galenos.2024.2024.0436
- By:
- Publication type:
- Article
Hypo-pigmented Lesions - Not as Innocuous as They Look.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 701, doi. 10.3390/cancers17040701
- By:
- Publication type:
- Article
Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 682, doi. 10.3390/cancers17040682
- By:
- Publication type:
- Article
Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16 , 2492
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 623, doi. 10.3390/cancers17040623
- By:
- Publication type:
- Article
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 598, doi. 10.3390/cancers17040598
- By:
- Publication type:
- Article
Epidemiology and Outcome of Primary Central Nervous System Tumors Treated at King Hussein Cancer Center.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 590, doi. 10.3390/cancers17040590
- By:
- Publication type:
- Article
Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Study in Chinese Patients.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 586, doi. 10.3390/cancers17040586
- By:
- Publication type:
- Article
Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 573, doi. 10.3390/cancers17040573
- By:
- Publication type:
- Article
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 572, doi. 10.3390/cancers17040572
- By:
- Publication type:
- Article
Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 568, doi. 10.3390/cancers17040568
- By:
- Publication type:
- Article
Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 563, doi. 10.3390/cancers17040563
- By:
- Publication type:
- Article
Omission of Axillary Surgery After Neoadjuvant Therapy in Her2-Positive Breast Cancer: Who Are the Candidates?
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 562, doi. 10.3390/cancers17040562
- By:
- Publication type:
- Article
Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 561, doi. 10.3390/cancers17040561
- By:
- Publication type:
- Article
Advancements in the Research of Astragalus membranaceus for the Treatment of Colorectal Cancer.
- Published in:
- American Journal of Chinese Medicine, 2025, v. 53, n. 1, p. 119, doi. 10.1142/S0192415X25500065
- By:
- Publication type:
- Article
In Reply to Letter From Parkash and Smith.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 3, p. 208, doi. 10.5858/arpa.2024-0417-LE
- By:
- Publication type:
- Article